awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35872579-9E810503-8F98-44C5-B0C3-1614A618CE03
Q35872579-9E810503-8F98-44C5-B0C3-1614A618CE03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35872579-9E810503-8F98-44C5-B0C3-1614A618CE03
Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.
P2860
Q35872579-9E810503-8F98-44C5-B0C3-1614A618CE03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35872579-9E810503-8F98-44C5-B0C3-1614A618CE03
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f33bee7160ca83c92c8868424ed8d87c5ef0218a
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.